Artemether
- Generic Name
- Artemether
- Brand Names
- Coartem
- Drug Type
- Small Molecule
- Chemical Formula
- C16H26O5
- CAS Number
- 71963-77-4
- Unique Ingredient Identifier
- C7D6T3H22J
- Background
Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infe...
- Indication
Artemether and lumefantrine combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 k...
- Associated Conditions
- Malaria, Acute, uncomplicated Malaria caused by plasmodium falciparum
- Associated Therapies
- -
A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours
- First Posted Date
- 2014-10-15
- Last Posted Date
- 2015-09-07
- Lead Sponsor
- LondonPharma Ltd.
- Target Recruit Count
- 87
- Registration Number
- NCT02263950
- Locations
- 🇬🇧
Guy's and St Thomas NHS Foundation Trust, London, United Kingdom
🇬🇧The Royal Surrey County Hospital, Guildford, Surrey, United Kingdom
Efficacy of ArTiMist™ in Children
- First Posted Date
- 2010-01-12
- Last Posted Date
- 2011-01-27
- Lead Sponsor
- Proto Pharma Ltd
- Target Recruit Count
- 31
- Registration Number
- NCT01047436
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.